Metabomed
PrivateLast Round
Series B
Dec 19, 2019
Total Funding Raised
$35.5M
Company Overview
Metabomed is a biotechnology company that develops small molecule drugs directed against novel targets in the field of cancer metabolism.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabomed Comparables
Compare Metabomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReEngage Therapeutics | 80% | |
| Lime Therapeutics | 73% | |
| KSQ Therapeutics | 71% |
Metabomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2019 | ||||
| Series A | Apr 4, 2016 | ||||
| Seed | Nov 28, 2013 |
Metabomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series A, Series B, Seed |
| Pontifax Venture Capital | Series A, Seed |
| Boehringer Ingelheim Venture Fund | Series A, Seed, Series B |
| Pfizer | Series A |
| Arkin Bio Ventures | Series B |
| Pfizer Ventures | Series B |
| Technion Research & Development Foundation | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2019
$13M round with participation from Pfizer Ventures and M Ventures.
- Apr 4, 2016
$18M round with participation from Pfizer and Boehringer Ingelheim.
Metabomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Metabomed's valuation, stock price, and market status.
Is Metabomed a public or private company?
Metabomed is a private company.
What is the current stock price of Metabomed?
Metabomed is a private company with no public stock price. Caplight tracks Metabomed's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Metabomed worth (valuation)?
Valuation information for Metabomed is not publicly available.
Can I buy Metabomed stock?
Metabomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Metabomed's last funding round?
Metabomed's most recent funding round was Series B on December 19, 2019.
Who are the main investors in Metabomed?
Key investors in Metabomed include M Ventures.
Will Metabomed IPO soon?
No public IPO plans have been announced for Metabomed.
How can I track Metabomed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Metabomed's secondary market activity and sign up for updates.